Cancer News

Recent research has unveiled critical mechanisms behind the formation of precancerous lesions in the pancreas, a development that could significantly impact the early detection and prevention of one...

Recent advancements in cancer treatment are offering new hope for patients battling advanced melanoma, a particularly aggressive form of skin cancer. Researchers at UT Southwestern Medical Center are...

Advancements in cancer treatment continue to evolve, offering new possibilities for patients battling advanced melanoma, a particularly aggressive form of skin cancer. Recent research highlights the...

In the realm of pediatric oncology, few endeavors are as critical as the pursuit of innovative treatments tailored specifically for children battling cancer. Dr. Jessica Sheth Bhutada, an attending...

The journey of surviving cancer is often accompanied by a daunting financial aftermath. While advancements in oncology have led to increased survival rates, the costs associated with ongoing care can...

Recent research from UCLA Health has unveiled a promising approach to predicting patient responses to combination immunotherapy in melanoma, a particularly aggressive form of skin cancer. By...

Recent updates from Inhibrx Biosciences regarding their investigational drug, ozekibart (INBRX-109), have sparked interest in the oncology community, particularly for patients suffering from...

In a significant move aimed at improving cancer education and outreach, the Association of American Cancer Institutes (AACI) has announced a partnership with Medlive, designating the latter as its...

The National Comprehensive Cancer Network (NCCN) recently celebrated significant achievements in cancer care at its 2026 Annual Conference in Orlando, Florida. The event highlighted the dedication of...

In a significant acknowledgment of dedication and innovation in cancer care, the National Comprehensive Cancer Network® (NCCN) recently celebrated the recipients of its annual awards during the NCCN...

Recent research has shed light on the challenging subtype of triple-negative breast cancer (TNBC) known as luminal androgen receptor (LAR). This subtype is notorious for its aggressive behavior and...

Recent research has shed light on the complexities of luminal androgen receptor (LAR) triple-negative breast cancer (TNBC), a subtype notoriously resistant to conventional treatments. This study from...

Recent research from the National University of Singapore (NUS) has unveiled a groundbreaking artificial intelligence (AI) model designed to better analyze protein interactions. Led by Professor...

Recent findings from a Phase 1 study conducted by the Dana-Farber Cancer Institute reveal important advancements in the treatment of advanced HER2-expressing malignancies, including ovarian and...

Recent findings presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 indicate that a novel combination therapy involving two investigational drugs, zedoresertib and...

The American Association for Cancer Research (AACR) Annual Meeting 2026, taking place from April 17-22 in San Diego, serves as a pivotal platform for advancing cancer research. Researchers from the...

The recent guidelines for breast cancer screening issued by the American College of Physicians (ACP) have ignited significant debate within the medical community. Critics argue that these...

Recent research from the Mayo Clinic is paving the way for a new era of personalized treatment for meningioma, the most prevalent form of primary brain tumor. This study emphasizes the importance of...

At the 2026 American Association for Cancer Research (AACR) Annual Meeting, researchers from The University of Texas MD Anderson Cancer Center presented groundbreaking findings that could reshape the...

In a significant development for cancer research and treatment, Caris Life Sciences has welcomed the UCSF Helen Diller Family Comprehensive Cancer Center into its Precision Oncology Alliance (POA)....